论文部分内容阅读
作者在先前的一个研究中曾发现,左心室肥厚在终末期肾脏病(ESRD)接受长期非卧床腹膜透析的患者中的患病率很高并似乎与病死率有很强的关联。本文旨在弄清左心室肥厚对经替代治疗(包括血液透析、间歇性的持续性腹膜透析以及肾移植)的更大的ESRD群体来说是否具有独立预后意义。 1983年1月至1987年8月作者所在单位共收治了390例作替代治疗的ESRD患者。经超声心动图检查
In a previous study, the authors found that the prevalence of left ventricular hypertrophy in patients undergoing end-stage renal disease (ESRD) undergoing long-term ambulatory peritoneal dialysis was high and appeared to be strongly associated with mortality. This article aims to determine whether left ventricular hypertrophy has an independent prognostic significance in the larger ESRD population of surrogate treatments, including hemodialysis, intermittent continuous peritoneal dialysis, and kidney transplantation. From January 1983 to August 1987, the author’s unit treated 390 ESRD patients undergoing replacement therapy. Echocardiography